3-{[(4-aminophenyl)sulfonyl]amino}benzenesulfonamide

ID: ALA14182

Chembl Id: CHEMBL14182

Cas Number: 16840-26-9

PubChem CID: 10663960

Max Phase: Preclinical

Molecular Formula: C12H13N3O4S2

Molecular Weight: 327.39

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ccc(S(=O)(=O)Nc2cccc(S(N)(=O)=O)c2)cc1

Standard InChI:  InChI=1S/C12H13N3O4S2/c13-9-4-6-11(7-5-9)21(18,19)15-10-2-1-3-12(8-10)20(14,16)17/h1-8,15H,13H2,(H2,14,16,17)

Standard InChI Key:  BYERREGDQUCYJP-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

CA1 Tclin Carbonic anhydrase I (13240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

CA4 Carbonic anhydrase IV (1713 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 327.39Molecular Weight (Monoisotopic): 327.0347AlogP: 0.72#Rotatable Bonds: 4
Polar Surface Area: 132.35Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 8.21CX Basic pKa: 2.08CX LogP: 0.24CX LogD: 0.18
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.71Np Likeness Score: -1.78

References

1. Scozzafava A, Supuran CT..  (2000)  Carbonic anhydrase inhibitors: synthesis of N-morpholylthiocarbonylsulfenylamino aromatic/heterocyclic sulfonamides and their interaction with isozymes I, II and IV.,  10  (10): [PMID:10843231] [10.1016/s0960-894x(00)00178-5]
2. Scozzafava A, Briganti F, Ilies MA, Supuran CT..  (2000)  Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes.,  43  (2): [PMID:10649985] [10.1021/jm990479+]
3. Scozzafava A, Briganti F, Mincione G, Menabuoni L, Mincione F, Supuran CT..  (1999)  Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route.,  42  (18): [PMID:10479300] [10.1021/jm9901879]
4. Agrawal VK, Singh J, Khadikar PV, Supuran CT..  (2006)  QSAR study on topically acting sulfonamides incorporating GABA moieties: a molecular connectivity approach.,  16  (7): [PMID:16458003] [10.1016/j.bmcl.2005.08.071]
5. Sethi KK, Verma SM, Prasanthi N, Sahoo SK, Parhi RN, Suresh P..  (2010)  3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors.,  20  (10): [PMID:20443227] [10.1016/j.bmcl.2010.03.104]
6. Vullo D, Luca VD, Scozzafava A, Carginale V, Rossi M, Supuran CT, Capasso C..  (2013)  The alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1 is highly susceptible to inhibition by sulfonamides.,  21  (6): [PMID:22883029] [10.1016/j.bmc.2012.07.024]

Source